Exidavnemab phase 2a study expanded to include MSA patients
Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/exidavnemab-phase-2a-study-expanded-to-include-msa-patients-302449984.html
en | boerse | 67932335 |
